Innovatus Life Sciences Acquisition Corp. (ILAC)

Chart not available yet

Market Cap	224.60M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	22.46M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings Date	n/a

About ILAC

Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin...

• Industry: Blank Checks / SPAC
• IPO Date: Pending
• CEO: David Schiff
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: ILAC

Full Company Profile

News

Innovatus Life Sciences Acquisition IPO Registration Document (S-1)

Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC